These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20496075)

  • 1. A novel BMPR2 mutation associated with pulmonary arterial hypertension in an octogenarian.
    Johri S; Dunnington GH; Vnencak-Jones CL
    Lung; 2010 Aug; 188(4):349-52. PubMed ID: 20496075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension.
    Hautefort A; Mendes-Ferreira P; Sabourin J; Manaud G; Bertero T; Rucker-Martin C; Riou M; Adão R; Manoury B; Lambert M; Boet A; Lecerf F; Domergue V; Brás-Silva C; Gomez AM; Montani D; Girerd B; Humbert M; Antigny F; Perros F
    Circulation; 2019 Feb; 139(7):932-948. PubMed ID: 30586714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Codependence of Bone Morphogenetic Protein Receptor 2 and Transforming Growth Factor-β in Elastic Fiber Assembly and Its Perturbation in Pulmonary Arterial Hypertension.
    Tojais NF; Cao A; Lai YJ; Wang L; Chen PI; Alcazar MAA; de Jesus Perez VA; Hopper RK; Rhodes CJ; Bill MA; Sakai LY; Rabinovitch M
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1559-1569. PubMed ID: 28619995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of mutations of activin receptor-like kinase 1 gene (ALK1) in addition to bone morphogenetic protein receptor II gene (BMPR2) in children with pulmonary arterial hypertension.
    Fujiwara M; Yagi H; Matsuoka R; Akimoto K; Furutani M; Imamura S; Uehara R; Nakayama T; Takao A; Nakazawa M; Saji T
    Circ J; 2008 Jan; 72(1):127-33. PubMed ID: 18159113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BMPR2 gene delivery reduces mutation-related PAH and counteracts TGF-β-mediated pulmonary cell signalling.
    Feng F; Harper RL; Reynolds PN
    Respirology; 2016 Apr; 21(3):526-32. PubMed ID: 26689975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary Hypertension Induced by Right Pulmonary Artery Occlusion: Hemodynamic Consequences of
    Todesco A; Grynblat J; Akoumia KKF; Bonnet D; Mendes-Ferreira P; Morisset S; Chemla D; Levy M; Méot M; Malekzadeh-Milani SG; Tielemans B; Decante B; Vastel-Amzallag C; Habert P; Ghigna MR; Humbert M; Montani D; Boulate D; Perros F
    J Am Heart Assoc; 2024 Jul; 13(14):e034621. PubMed ID: 38979789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal Transformation.
    Tian W; Jiang X; Sung YK; Shuffle E; Wu TH; Kao PN; Tu AB; Dorfmüller P; Cao A; Wang L; Peng G; Kim Y; Zhang P; Chappell J; Pasupneti S; Dahms P; Maguire P; Chaib H; Zamanian R; Peters-Golden M; Snyder MP; Voelkel NF; Humbert M; Rabinovitch M; Nicolls MR
    Circulation; 2019 Oct; 140(17):1409-1425. PubMed ID: 31462075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin-Bone morphogenetic protein type 2 receptor interaction induces pulmonary artery smooth muscle cell hyperplasia in pulmonary arterial hypertension.
    Maruyama H; Dewachter C; Belhaj A; Rondelet B; Sakai S; Remmelink M; Vachiery JL; Naeije R; Dewachter L
    J Heart Lung Transplant; 2015 Mar; 34(3):468-78. PubMed ID: 25447587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and genetic characteristics of pulmonary arterial hypertension in Lebanon.
    Abou Hassan OK; Haidar W; Nemer G; Skouri H; Haddad F; BouAkl I
    BMC Med Genet; 2018 May; 19(1):89. PubMed ID: 29843651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension.
    Girerd B; Montani D; Eyries M; Yaici A; Sztrymf B; Coulet F; Sitbon O; Simonneau G; Soubrier F; Humbert M
    Respir Res; 2010 Jun; 11(1):73. PubMed ID: 20534176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EIF2AK4 mutation as "second hit" in hereditary pulmonary arterial hypertension.
    Eichstaedt CA; Song J; Benjamin N; Harutyunova S; Fischer C; Grünig E; Hinderhofer K
    Respir Res; 2016 Nov; 17(1):141. PubMed ID: 27809840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMPR2 gene mutation in pulmonary arteriovenous malformation and pulmonary hypertension: a case report.
    Handa T; Okano Y; Nakanishi N; Morisaki T; Morisaki H; Mishima M
    Respir Investig; 2014 May; 52(3):195-8. PubMed ID: 24853021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel promoter and exon mutations of the BMPR2 gene in Chinese patients with pulmonary arterial hypertension.
    Wang H; Li W; Zhang W; Sun K; Song X; Gao S; Zhang C; Hui R; Hu H
    Eur J Hum Genet; 2009 Aug; 17(8):1063-9. PubMed ID: 19223935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The BMPR2 missense mutation p.K230N and pulmonary arterial hypertension.
    Hayes D; Ramanathan C; Kopp BT
    Pediatr Pulmonol; 2014 Jan; 49(1):E5-6. PubMed ID: 23139147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bone morphogenetic protein type II receptor gene promoter mutation-142G > A in a patient with familial pulmonary arterial hypertension].
    Li W; Hu H
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):230-4. PubMed ID: 19552837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BMPR2 germline mutation in chronic thromboembolic pulmonary hypertension.
    Feng YX; Liu D; Sun ML; Jiang X; Sun N; Mao YM; Jing ZC
    Lung; 2014 Aug; 192(4):625-7. PubMed ID: 24728306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BMPR2 gene therapy for PAH acts via Smad and non-Smad signalling.
    Harper RL; Reynolds AM; Bonder CS; Reynolds PN
    Respirology; 2016 May; 21(4):727-33. PubMed ID: 26809239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation.
    Sztrymf B; Coulet F; Girerd B; Yaici A; Jais X; Sitbon O; Montani D; Souza R; Simonneau G; Soubrier F; Humbert M
    Am J Respir Crit Care Med; 2008 Jun; 177(12):1377-83. PubMed ID: 18356561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of bone morphogenetic protein receptor 2 is associated with abnormal DNA repair in pulmonary arterial hypertension.
    Li M; Vattulainen S; Aho J; Orcholski M; Rojas V; Yuan K; Helenius M; Taimen P; Myllykangas S; De Jesus Perez V; Koskenvuo JW; Alastalo TP
    Am J Respir Cell Mol Biol; 2014 Jun; 50(6):1118-28. PubMed ID: 24433082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCL5 deficiency rescues pulmonary vascular dysfunction, and reverses pulmonary hypertension via caveolin-1-dependent BMPR2 activation.
    Nie X; Tan J; Dai Y; Liu Y; Zou J; Sun J; Ye S; Shen C; Fan L; Chen J; Bian JS
    J Mol Cell Cardiol; 2018 Mar; 116():41-56. PubMed ID: 29374556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.